Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States

被引：12
作者：
Sarpatwari, Ameet [1 ]
Choudhry, Niteesh K.
Avorn, Jerry
Kesselheim, Aaron S.
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA
来源：
PLOS MEDICINE | 2015年 / 12卷 / 03期
关键词：
DECISION-SUPPORT; BIOEQUIVALENCE; METAANALYSIS;
D O I：
10.1371/journal.pmed.1001802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：10
相关论文
共 51 条
  • [1] Alliance for Safe Biologics, 2012, ASBM ADV BOARD MEMB
  • [2] ALOSA Foundation, 2014, IS AC DET US
  • [3] American Medical Association, 2014, FREQ ASK QUEST PHYS
  • [4] American Medical Association Council on Science and Public Health, 2007, GEN SUBST NARR THER
  • [5] [Anonymous], DIRTY MED
  • [6] Doctors and drug companies
    Blumenthal, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (18) : 1885 - 1890
  • [7] Buehler G, 2010, HIST BIOQUIVANCE CRI
  • [8] Centers for Medicare and Medicaid, 2014, NHE FACTSH
  • [9] Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
    Davit, Barbara M.
    Nwakama, Patrick E.
    Buehler, Gary J.
    Conner, Dale P.
    Haidar, Sam H.
    Patel, Devvrat T.
    Yang, Yongsheng
    Yu, Lawrence X.
    Woodcock, Janet
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) : 1583 - 1597
  • [10] Dong B J, 1991, J Am Board Fam Pract, V4, P167
123456